Latest Insider Transactions at Eli Lilly & CO (LLY)
This section provides a real-time view of insider transactions for Eli Lilly & CO (LLY). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ELI LILLY & Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ELI LILLY & Co's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 18
2023
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
25
+0.16%
|
$14,275
$571.28 P/Share
|
|
Sep 18
2023
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
20
+0.04%
|
$11,420
$571.28 P/Share
|
|
Sep 18
2023
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
17
+0.02%
|
$9,707
$571.28 P/Share
|
|
Sep 12
2023
|
Alonzo Weems EVP, ERM & CECO |
SELL
Bona fide gift
|
Direct |
760
-9.79%
|
-
|
|
Sep 12
2023
|
Alonzo Weems EVP, ERM & CECO |
SELL
Open market or private sale
|
Direct |
1,148
-12.89%
|
$677,320
$590.98 P/Share
|
|
Sep 07
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
210,000
-0.02%
|
$119,700,000
$570.22 P/Share
|
|
Aug 31
2023
|
Eric Dozier EVP, Chief People Officer |
SELL
Bona fide gift
|
Direct |
546
-8.02%
|
-
|
|
Aug 31
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
46,541
-0.01%
|
$25,830,255
$555.88 P/Share
|
|
Aug 30
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
6,181
-0.0%
|
$3,430,455
$555.74 P/Share
|
|
Aug 29
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
28,747
-0.01%
|
$15,925,838
$554.96 P/Share
|
|
Aug 28
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
37,660
-0.02%
|
$10,444,172,480
$277328.27 P/Share
|
|
Aug 25
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
63,572
-0.02%
|
$35,282,460
$555.22 P/Share
|
|
Aug 24
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
20,992
-0.01%
|
$11,650,560
$555.47 P/Share
|
|
Aug 23
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
1,307
-0.0%
|
$725,385
$555.69 P/Share
|
|
Aug 21
2023
|
Donald A Zakrowski SVP, Finance, & CAO |
SELL
Open market or private sale
|
Direct |
600
-10.04%
|
$327,600
$546.51 P/Share
|
|
Aug 21
2023
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
18
+0.83%
|
$9,900
$550.5 P/Share
|
|
Aug 21
2023
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
26
+0.17%
|
$14,300
$550.5 P/Share
|
|
Aug 21
2023
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
9
+0.53%
|
$4,950
$550.5 P/Share
|
|
Aug 21
2023
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
18
+0.03%
|
$9,900
$550.5 P/Share
|
|
Aug 21
2023
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
18
+1.74%
|
$9,900
$550.5 P/Share
|
|
Aug 21
2023
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
21
+0.04%
|
$11,550
$550.5 P/Share
|
|
Aug 15
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
50,222
-0.01%
|
$27,220,324
$542.8 P/Share
|
|
Aug 14
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
164,778
-0.03%
|
$88,980,120
$540.4 P/Share
|
|
Aug 11
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
83,039
-0.02%
|
$43,927,631
$529.82 P/Share
|
|
Aug 10
2023
|
Daniel Skovronsky EVP, CSO & Pres. LRL & LLY Imm |
SELL
Bona fide gift
|
Direct |
249
-0.24%
|
-
|
|
Aug 10
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
3,000
-0.0%
|
$1,584,000
$528.13 P/Share
|
|
Aug 09
2023
|
David A Ricks President, Chair, and CEO |
SELL
Bona fide gift
|
Direct |
9,550
-2.12%
|
-
|
|
Aug 09
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
123,961
-0.02%
|
$65,699,330
$530.36 P/Share
|
|
Aug 08
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
204,409
-0.01%
|
$106,497,089
$521.62 P/Share
|
|
Jul 21
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
591
-0.0%
|
$275,406
$466.62 P/Share
|
|
Jul 17
2023
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
32
+0.21%
|
$14,304
$447.14 P/Share
|
|
Jul 17
2023
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.65%
|
$4,917
$447.14 P/Share
|
|
Jul 17
2023
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
22
+2.15%
|
$9,834
$447.14 P/Share
|
|
Jul 17
2023
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
22
+1.02%
|
$9,834
$447.14 P/Share
|
|
Jul 17
2023
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
25
+0.05%
|
$11,175
$447.14 P/Share
|
|
Jul 17
2023
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
22
+0.03%
|
$9,834
$447.14 P/Share
|
|
Jun 30
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
164,125
-0.03%
|
$76,646,375
$467.45 P/Share
|
|
Jun 29
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
44,115
-0.04%
|
$20,513,475
$465.08 P/Share
|
|
Jun 28
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
11,760
-0.01%
|
$5,468,400
$465.78 P/Share
|
|
Jun 22
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
107,022
-0.01%
|
$49,016,076
$458.99 P/Share
|
|
Jun 21
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
31,454
-0.02%
|
$14,280,116
$454.54 P/Share
|
|
Jun 20
2023
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
21
+0.98%
|
$9,471
$451.95 P/Share
|
|
Jun 20
2023
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
32
+0.21%
|
$14,432
$451.95 P/Share
|
|
Jun 20
2023
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.65%
|
$4,961
$451.95 P/Share
|
|
Jun 20
2023
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
22
+0.03%
|
$9,922
$451.95 P/Share
|
|
Jun 20
2023
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
22
+2.2%
|
$9,922
$451.95 P/Share
|
|
Jun 20
2023
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
25
+0.05%
|
$11,275
$451.95 P/Share
|
|
Jun 20
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
34,156
-0.03%
|
$15,506,824
$454.08 P/Share
|
|
Jun 16
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
25,015
-0.01%
|
$11,381,825
$455.53 P/Share
|
|
Jun 15
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
27,353
-0.01%
|
$12,418,262
$454.59 P/Share
|